Related Experiment Videos
[Angioplasty in primary Budd-Chiari syndrome. Apropos of 3 cases]
Insights
Percutaneous transluminal angioplasty shows limited success for irregular Budd-Chiari syndrome stenoses. However, it is effective for membrane-related stenosis, though recurrence is possible, suggesting pre-operative use.
Area of Science:
- Vascular Surgery
- Interventional Radiology
Background:
- Budd-Chiari syndrome is a rare condition characterized by hepatic venous outflow obstruction.
- Primary Budd-Chiari syndrome necessitates effective treatment strategies to improve patient outcomes.
Observation:
- Three patients with primary Budd-Chiari syndrome underwent percutaneous transluminal angioplasty.
- The study observed the response of different types of stenoses to the angioplasty procedure.
Findings:
- Angioplasty demonstrated a poor response in cases of irregular stenoses within the suprahepatic vessels.
- A good initial response was noted for stenoses caused by membranes, but recurrence occurred within months.
- The efficacy of angioplasty for suprahepatic or caval membranes was transient.
Implications:
- Percutaneous transluminal angioplasty may serve as a valuable pre-operative intervention for Budd-Chiari syndrome caused by suprahepatic or caval membranes.
- Further research is warranted to optimize angioplasty techniques and manage recurrence for improved long-term outcomes in Budd-Chiari syndrome.
- This study highlights the importance of differentiating stenosis types for effective treatment planning in Budd-Chiari syndrome.
Abstract:
Three patients with the primary Budd-Chiari syndrome were treated by percutaneous transluminal angioplasty. Results showed an apparent poor response to angioplasty of irregular stenoses of the suprahepatic vessels and a good response when stenosis was due to membrane, but recurrence of the latter lesion after several months. The transient efficacy of this procedure in cases with a suprahepatic or caval membrane suggests that it be used pre-operatively for this indication.